(Q41940311)

14 October 2017

title

Accumulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultured cerebellar astrocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1548462

7 October 2022

1 reference

A. M. Marini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1548462

7 October 2022

R. H. Lipsky

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1548462

7 October 2022

J. P. Schwartz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1548462

7 October 2022

I. J. Kopin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1548462

7 October 2022

language of work or name

English

0 references

publication date

1 April 1992

1 reference

Journal of Neurochemistry

14 October 2017

published in

1 reference

14 October 2017

volume

58

1 reference

14 October 2017

issue

4

1 reference

14 October 2017

page(s)

1250-1258

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Evidence for neuromelanin involvement in MPTP-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Commentary. Lysosomotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Changes in nuclear proteins of astrocytes as a result of acute ammonia or ethanol exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Pharmacology and toxicology of the monovalent carboxylic ionophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB11336.X

10.1111/J.1471-4159.1992.TB11336.X

21 January 2018

Identifiers

DOI

1 reference

14 October 2017

1 reference